enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.31% | 6.47% | -3.02% | 17.69% | 32.19% |
| Total Depreciation and Amortization | 279.31% | -76.61% | 5.98% | -2.50% | -7.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.34% | -18.48% | -28.21% | -1.51% | -52.27% |
| Change in Net Operating Assets | 262.72% | -1,370.37% | 95.00% | 22.86% | -152.79% |
| Cash from Operations | 10.45% | -9.60% | 5.95% | 21.61% | -18.22% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -25.42% | 32.38% | -33.76% | 14.54% | 29.15% |
| Cash from Investing | -25.42% | 32.38% | -33.76% | 14.54% | 29.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.41% | -- | -- | 224.48% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 48.41% | -- | -- | 224.48% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -204.92% | 152.14% | -130.77% | 404.20% | 44.01% |